Protocol summary

Study aim
Determining the effect of the traditional product of Plantago major, and Rheum on the clinical symptoms of mild to moderate ulcerative colitis patients compared to placebo
Design
The clinical trial has a control group, double-blind, randomized, on 60 patients, randomly block in 4 blocks of four
Settings and conduct
Two groups of 30 patients in Kerman University of Medical Sciences, who were assigned randomly (random block) to the drug and placebo groups, follow-up and the desired response will be recorded at the beginning of the study, 3, 6 and 10 weeks.
Participants/Inclusion and exclusion criteria
Inclusion criteria: patients aged 18 to 60 with mild and moderate ulcerative colitis confirmed by Endoscopy and biopsy and with the diagnosis of gastroenterologist who signed the informed consent form have no exclusion criteria. Exclusion criteria: pregnancy or breastfeeding; use of antibiotics; NSAIDs OCPs or hormone therapy (in the last 2 weeks); suffering from disease complications; simultaneous suffering from serious diseases Liver, kidney, heart, cancer or celiac disease; smoking or drug addiction; suffering from other diseases Autoimmunity; simultaneous use of other traditional medicine and complementary medicine.
Intervention groups
Intervention group: consumes 2 capsules daily (1 in the morning and 1 in the evening) before meals. The capsule contains 2 parts of gourd extract and one part of rhubarb extract. Control group: consumes 2 capsules daily (1 in the morning and 1 in the evening). The capsule contains an equal volume of corn starch.
Main outcome variables
Partial Mayo score; Quality of Life; anxiety; depression; Stress

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20150927024228N5
Registration date: 2023-12-18, 1402/09/27
Registration timing: prospective

Last update: 2023-12-18, 1402/09/27
Update count: 0
Registration date
2023-12-18, 1402/09/27
Registrant information
Name
Maryam Azimi
Name of organization / entity
Kerman University Of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 34 3312 2020
Email address
m_azimidehali@collegian.kmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-03-10, 1402/12/20
Expected recruitment end date
2025-03-10, 1403/12/20
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Efficacy of formula of Plantago major, and Rheum khorasanicum on clinical symptoms of patient with mild to moderate ulcerative colitis: a double blind randomized clinical trial
Public title
Investigation of the effect of Plantago major, and Rheum on colitis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients aged 18 to 60 with mild and moderate ulcerative colitis confirmed by endoscopy and biopsy and diagnosed by a gastroenterologist who signed the informed consent form and did not meet the exclusion criteria.
Exclusion criteria:
Pregnancy or breastfeeding Taking antibiotics Taking herbal medicines, NSAIDs, OCPs or hormone therapy (in the last 2 weeks) Complications of the disease (such as massive bleeding requiring hospitalization or emergency surgery, fulminant colitis, peritonitis, toxic megacolon, obstructive stenosis), Suffering from liver, kidney, heart, cancer or celiac disease at the same time Addiction to smoking or drugs Suffering from other autoimmune diseases
Age
From 18 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Patients with mild to moderate ulcerative colitis based on Partial Mayo score, and inclusion, and exclusion criteria, will be entered into Excel file (Microsoft Excel® software 2021), then randomly sorted through using "RAND", and "INDEX" formulas. Then, simple randomized patients, in the order of the list of excel, will be entered into the two groups of the study (drug, or placebo) according to the list of 6 blocks of 4 below (ABAB, BABA, ABBA, BAAB, AABB, BBAA) by a trained secretory, who is blinded in details of the study, based on randomized excel file.
Blinding (investigator's opinion)
Double blinded
Blinding description
Medicines and placebos are prepared by a traditional pharmacy specialist in the laboratory of the Iranian Faculty of Medicine, and after homogenization in terms of shape, smell, and color, they are provided to the researcher in completely similar packages.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Afzalipour Medical Education Center, Kerman University of Medical Sciences (Research Ethics Committ
Street address
Afzalipour hospital, Emam Khomeini highway
City
Kerman
Province
Kerman
Postal code
7616913911
Approval date
2023-02-14, 1401/11/25
Ethics committee reference number
IR.KMU.AH.REC.1402.002

Health conditions studied

1

Description of health condition studied
Ulcerative colitis
ICD-10 code
K51
ICD-10 code description
Ulcerative colitis

Primary outcomes

1

Description
Partial Mayo score
Timepoint
At the beginning of the study, 3, 6 and 10 weeks
Method of measurement
Partial Mayo score questionnaire

Secondary outcomes

1

Description
Quality of life
Timepoint
At the beginning of the study, 3, 6 and 10 weeks
Method of measurement
Quality of life questionnaire (IBDQ-9)

2

Description
Anxiety, stress, and depression
Timepoint
At the beginning of the study, 3, 6 and 10 weeks
Method of measurement
DASS-21 questionnaire

Intervention groups

1

Description
Intervention group: consumes 2 capsules daily contain two parts of Plantago major extract, and one part of Rheum khorasanicum prepared by the pharmacist in the pharmaceutical laboratory (1 in the morning and 1 in the evening) with a glass of water and before meals and with an interval of one hour from the mesalamine drug.
Category
Treatment - Drugs

2

Description
Control group: consumes 2 capsules contain corn starch prepared by the pharmacist in the pharmaceutical laboratory daily (1 in the morning and 1 in the evening) with a glass of water and before meals and with an interval of one hour from the mesalamine drug.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Kerman University of Medical Sciences
Full name of responsible person
Maryam Azimi
Street address
Afzalipour hospital, Emam Khomeini highway
City
Kerman
Province
Kerman
Postal code
7616913911
Phone
+98 34 3322 2250
Email
dr.azimm@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Abedin Iranpour
Street address
Afzalipour hospital, Emam Khomeini highway
City
Kerman
Province
Kerman
Postal code
7619813159
Phone
+98 34 3226 3855
Email
a.iranpour@kmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kerman University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Maryam Azimi
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Traditional Medicine
Street address
Afzalipour hospital, Emam Khomeini highway
City
Kerman
Province
Kerman
Postal code
7616913555
Phone
+98 34 3211 0123
Email
Dr.azimm@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Azimi Maryam
Position
Assistant professor of Kerman University of Medical Sciences
Latest degree
Ph.D.
Other areas of specialty/work
Traditional Medicine
Street address
Afzalipour hospital, Emam Khomeini highway
City
Kerman
Province
Kerman
Postal code
7616913555
Phone
+98 34 3132 8000
Fax
+98 34 3132 8000
Email
dr.azimm@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Ebrahim Shamsuddini
Position
Ph.D student of Persian medicine
Latest degree
Medical doctor
Other areas of specialty/work
Traditional Medicine
Street address
hakim 32, Hakim Boulevard
City
Kerman
Province
Kerman
Postal code
7615785354
Phone
+98 34 3312 6132
Email
kamashams@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...